Tailored-treatment for early stage Hodgkin's disease
Ron Epelbaum(University of Bern), Nissim Haim(Technion – Israel Institute of Technology), N. Menashe, D. Avital, G. Dahan, Charles Rosenbaum, Y Ben-Arie, David Faraggi(Carmel (Israel)), Menachem Ben-Shahar(Technion – Israel Institute of Technology), A. Kuten
Cited by 0
Related Papers
Curcumin as an Anti-Cancer Agent: Review of the Gap Between Basic and Clinical Applications
|Current Medicinal Chemistry|2009|480
Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers
|British Journal of Cancer|2014|444
<sup>18</sup>F-FDG Avidity in Lymphoma Readdressed: A Study of 766 Patients
|Journal of Nuclear Medicine|2009|381
Curcumin and Gemcitabine in Patients With Advanced Pancreatic Cancer
|Nutrition and Cancer|2010|279